n this DocTalk, Dr. Chris Lieu goes over CRC screening tests, including newer DNA-based tests that focus on CRC and multi-cancer early detection tests, designed for patients without a history of colon cancer. In the second part of his talk, he covers the CIRCULATE-US trial for high-risk stage II and III colon cancer patients, which as of May 2022 is currently enrolling. This trial will address questions around the clinical utility of Minimal Residual Disease ctDNA testing. More details on this study are available here.
Please see the Lecture Hall in ColonTown for more great content on colorectal cancer! Many thanks to the ColonTown team and Manju George for the great content.
